Status:
TERMINATED
Cognitive Impact of Benzodiazepin Withdrawn After Curative Epilepsy Surgery in Children With Focal Epilepsy
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Cognitive Impact of Antiepileptic Drugs
Eligibility:
All Genders
6-14 years
Brief Summary
Epilepsy is a frequent group of diseases, affecting 1% of the general population with a higher incidence in children. Anti-epileptic drugs are used as part of the drug treatment. Even if children with...
Detailed Description
1. Research Assumptions Epilepsy is a frequent group of diseases, affecting 1% of the general population with a higher incidence in children. Anti-epileptic drugs are used as the main treatment. The c...
Eligibility Criteria
Inclusion
- Inclusion criteria :
- Children aged 6 years to 14 years and 10 months
- Epilepsy patients with drug-resistant focal epilepsy with programmed curative surgical management
- Subject with IQ greater than 70 (Evaluation of IQ in pre-surgical evaluation)
- Antiepileptic drug regimen comprising a benzodiazepine daily
- Subject beneficiary of French national social security scheme
- Parental (and the child if he or she is of age to do so) have signed the study consent
Exclusion
- Patient unable to perform cognitive tests or unwilling to do them
- Planned change in drug regimen before the post-surgical period
- Denied to participate in the research
Key Trial Info
Start Date :
September 9 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT03803046
Start Date
September 9 2019
End Date
September 30 2020
Last Update
March 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Robert-Debré
Paris, Île-de-France Region, France, 75019